Skip to main content
    E

    EyePoint, Inc (EYPT)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $0.31
    +0.00 (+0.52%)

    Market Cap: $34.82M

    Last updated: Nov 17, 2026 at 11:05 AM ET

    EyePoint, Inc (EYPT) Stock Forecast

    Updated Nov 17, 2026. Estimates and ratings come from consensus analyst data.

    Analysts expect EyePoint (EYPT) to earn -$3.62 per share in the fiscal year ending Dec 31, 2026, on revenue of $1.70M. Of 13 analysts, 3 rate the stock Buy or Strong Buy, 9 Hold and 1 Sell or Strong Sell, for a consensus of Hold. Over the last 30 days, 5 estimates for the fiscal year ending Dec 31, 2026 were revised up and 2 down.

    Analyst Ratings

    Scoring Strong Buy as 1 and Strong Sell as 5, the 13 ratings average 2.92, inside the Hold band from 2.5 up to 3.5. Buy and Strong Buy make up 23% of the ratings.

    RatingAnalystsShare
    Strong Buy00.0%
    Buy323.1%
    Hold969.2%
    Sell00.0%
    Strong Sell17.7%
    Consensus
    Hold
    Total analysts
    13

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Annual Estimates

    From the first fiscal year below to the second, the EPS consensus shows a smaller loss and revenue estimates rise 126.5%.

    Fiscal year ending Dec 31, 2026
    -$3.62
    EPS consensus, revenue $1.70M
    Fiscal year ending Dec 31, 2027
    -$2.07
    EPS consensus, revenue $3.85M
    Next report
    Mar 2, 2027
    Estimated

    EPS range

    Fiscal year endingEPS consensusEPS rangeEPS analystsRevenue consensusRevenue rangeRev. analysts
    Dec 31, 2026-$3.62-$4.24 to -$2.6811$1.70M$1.00M to $2.70M13
    Dec 31, 2027-$2.07-$4.14 to -$0.7211$3.85MN/A13

    Quarterly Estimates

    Quarter endingEPS consensusEPS rangeEPS analystsRevenue consensusRevenue rangeRev. analysts
    Dec 31, 2026-$0.69-$0.91 to -$0.3815$309845N/A15

    Estimate Revisions

    Across the 2 periods below, the last 30 days brought 9 upward and 3 downward EPS revisions. Raises outnumber cuts in every period.

    PeriodUp 30 daysDown 30 days
    Fiscal year ending Dec 31, 202652
    Fiscal year ending Dec 31, 202741

    EPS Trend

    Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has worsened from -$3.55.

    PeriodNow7 days ago30 days ago60 days ago90 days agoChange
    Fiscal year ending Dec 31, 2026-$3.62-$3.62-$3.72-$3.72-$3.55N/A
    Fiscal year ending Dec 31, 2027-$2.07-$2.20-$2.77-$2.77-$3.04N/A

    Frequently Asked Questions About EYPT

    What is the EYPT stock forecast?

    Consensus analyst estimates put EyePoint's EPS at -$3.62 for the fiscal year ending Dec 31, 2026, on revenue of $1.70M. The consensus rating from 13 analysts is Hold.

    How do analysts rate EYPT stock?

    Of 13 analysts covering EyePoint, 0 rate it Strong Buy, 3 Buy, 9 Hold, 0 Sell and 1 Strong Sell, for a consensus of Hold.

    What EPS do analysts expect from EYPT next year?

    For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is -$3.62, with estimates from -$4.24 to -$2.68 from 11 analysts. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is -$2.07, with estimates from -$4.14 to -$0.72 from 11 analysts.

    What revenue do analysts expect from EyePoint next year?

    For the fiscal year ending Dec 31, 2026, the consensus revenue estimate is $1.70M, with estimates from $1.00M to $2.70M. For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $3.85M.

    How many analysts cover EYPT?

    13 analysts rate EyePoint stock, and 11 analysts estimate its EPS for the fiscal year ending Dec 31, 2026.